APAC Cell & Gene Therapy Center

Bring new cell and gene therapies to market faster.

The growth of cell and gene therapies require new thinking around development, administration, value, and reimbursement. Over 18,000 patients from 70 countries globally have participated in 210 cell and gene therapy trials since 2012. These advances in cell and gene therapy represent innovative treatments, particularly where traditional methods fall short, but require navigating new risks. Our multidisciplinary teams are ready to deliver life-changing treatments to patients sooner.
Biotechnology research

End-to-end cell and gene therapy expertise with proven track record of success

IQVIA brings together exceptional expertise in Cell and Gene Therapy (CAGT) across the Cell and Gene Therapy development lifecycle, to help you increase the efficiency of your program and maximize the value of new therapies.

hospital brainstorm meeting
Doctor and patient viewing tablet

Therapeutic expertise — hands-on and hand-selected for biotech

Therapeutically aligned solutions to advance your clinical program to the next milestone.

Medical professionals observing demonstration

View Regional Sites

If you are interested, learn more about our regional Cell and Gene Therapy centers of excellence in these country locations:

Contact Us